Sylvia Cheung | CFO |
Joseph Darling | President and CEO |
Mike Petusky | Barrington Research |
Joe Munda | First Analysis |
Jim Sidoti | Sidoti & Company |
Lisa Springer | Singular Research |
Andy Summers | Summers Value Partners |
Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] And I will now turn the call over to Sylvia Cheung, Chief Financial Officer. Please proceed.